Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II trial of carboplatin + paclitaxel with or without bevacizumab in advanced or recurrent chemotherapy-naive endometrial cancer
2011-003301-16Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Dec 2011
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in endometrial cancer (EC) comparing Carboplatin + paclitaxel with Carboplatin + paclitaxel + bevacizumab (2 arms). Primary endpoint: Progression-free survival. Started Dec 2011; status: completed.
02
Drugs
bevacizumabpaclitaxelcarboplatin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on 2011-003301-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003301-16.